Related Articles

• 13 New Stem Cell Lines Approved for Researchers
• 2009 Top 10 Innovations
• After Stem-Cell Breakthrough, the Work Begins
• Bill Takes Aim at CIRM Governance
• Biomedical Companies Sharing Data to Speed Development of Therapies
• Biotechs Anticipate Pricing Pressure From New Administration
• California Healthcare Institute Submits Statement to California Institute for Regenerative Medicine Revised Intellectual Property Regulation
• Cellular Reprogramming Eliminates Big Hurdle to Develop New Transplant Therapies
• CHI Applauds President Obama's Expansion of Federal Funding for Stem Cell Research
• CHI Blog Executive Spotlight Features Jeffrey Janus of International Stem Cell Corporation
• CHI Patient Perspectives Podcast Series Premieres
• CHI Policy Agendas Outline Priorities for 2009
• CHI Recognizes National Lab Day Today
• CIRM Grants $16 Million to Stem Cell Researchers
• CIRM Grants $67.7 Million for Stem Cell Research
• CIRM Seeks to Protect Exclusivity for Biosimilars
• City of Hope Receives FDA Approval to Conduct First Clinical Study of Stem Cell-Based Therapy
• Congress Works to Resolve Differences in Healthcare Reform Bills
• Consumer Genetics Industry to Face Regulatory Changes
• Cutting-edge Medical Technologies Showing Promise in the HIV/AIDS Fight
• Early-Stage Hair-Growth Trial Shows Promising Results
• Embryonic stem cell patent claims confirmed, but narrowed
• FDA Suggests 510(k) Review to Be Released Soon
• Gen-Probe Collaboration on New Diagnostic Systems
• Illumina Introduces Sophisticated Genome Technology
• J. David Gladstone Researchers Discover Breakthrough in Heart Cell Research
• Justice Department Seeks Stem-Cell Ruling Stay
• Last Chance To Register Today For FDA 510(k) Event
• New Stem Cell Technique Unveiled
• Obama Lifts Bans on Stem Cell Research
• OncoMed and Bayer in Strategic Stem Cell Collaboration
• Patients Share Their Stories at the 2010 California Biomedical Industry Report Launch Feb. 2 in Sacramento
• President Obama Recognizes Top Scientists and Innovators
• Private Donations for Stem Cell Grants Exceed Expectations
• PTO Upholds Key Stem Cell Patent
• Registration Deadline Tomorrow For FDA 510(k) Event
• Report: Diagnostic Tests Are Crucial to Health Reform
• Researchers Await Federal Stem Cell Funding
• Salk Institute Scientists Make Breakthrough in Stem Cell Therapy
• San Diego Stem Cell Consortium Receives $30 Million Gift
• Schwarzenegger Touts State's Biomedical Industry
• Six Institutions to Focus on Stem Cells
• Stanford University to Offer New Genotyping Class
• State Agency Allots $13 Million for San Diego Stem Cell Researchers
• Stem Cell Bill Re-introduced to Senate
• Stem Cell Funding Lift Good for California Businesses
• Stem Cell Research to Start Delivering on Promise
• Stem Cell Researchers Await Executive Order on Research Restrictions
• Stem Cell Therapy Breakthrough May Have Implications for Major Diseases
• Stem Cells Hold Promise in Treating Vision Loss
• Stem-Cell Bill on the Table?
• Stem-cell Cash Flows; Discounts Seek to Stretch $274 Million
• Study: Stem Cells May Restore Brains Damaged by Radiation
• Study: U.S. at Risk of Losing Global Lead in Medical Innovation
• Successful Cloning of Human Embryo Documented by San Diego Company
• The Salk Institute Teams Up with Sanofi-Aventis
• UCI Home to New Stem Cell Research Hub
• UCLA Researchers Reprogram Skin Cells to Act Like Embryonic Stem Cells
• UCSF Stem Cell Researcher Receives International Award
• 'Virtual’ Incubator Aims to Pair Startups with Resources
• Administration Unveils Strategy for Health Emergencies
• Arena’s Obesity Drug Trial Shows Patients Lose Moderate Amount of Weight
• BioMarin, Buck Institute Join Forces for Alzheimer’s Research
• Biomedical Industry Becomes Increasingly Vital to State's Economic Stability, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biomedical Industry Jobs Critical to California’s Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biotech Industry Attracts the Most Venture Capital
• Body Clock Drug Offers Hope for Treating Jet Lag, Depression
• California Biomedical Community Honors Congresswoman Anna Eshoo
• California Healthcare Institute Supports Introduction of Biosimilars Legislation
• California Scientists Sound Alarms About National Institutes of Health
• Cancer Major Focus of R&D Efforts in California, but Cures Hard to Come By
• Celebrating Global and Local Biotech Breakthroughs in San Diego
• Celera's Blood Test May Diagnose Lung Cancer
• Cepheid Test Detects TB Within Two Hours
• Cephied Receives FDA Clearance to Market First-ever Molecular Testing Device
• CHI Announces Dr. Topol as Keynote Speaker
• CHI Blog Interviews Mark Smith, M.D., President and CEO of California HealthCare Foundation, Speaker at the 2009 California Healthcare Policy Forum
• CHI Blog: Executive Spotlight: Melinda Richter, Executive Director, San Jose BioCenter
• CHI in Washington, D.C.: Inform. Innovate. Inspire.
• CHI Interviews Mireille Gingras, Ph.D., President and CEO of HUYA Biosciences International
• CHI Joins Coalition in Support of National Pedigree Standard
• CHI Launches Podcast to Help Entrepreneurs Find New Sources of Funding
• CHI Members Called to Help Combat Swine Flu
• CHI Patient Perspectives Podcast Series New Episode: A New Model for Funding Research
• CHI Patient Perspectives Podcast Series New Episode: Finding a Cure: Duchenne
• CHI Reporting from 2009 BIO Convention in Atlanta
• CHI to Launch 2010 California Biomedical Industry Report Feb. 2 in Sacramento
• CHI's First-Ever Environmental Summit - March 1 Deadline - Act Fast!
• CHI's Inaugural Environmental Summit Brings Robust Debate and Dialogue
• Commentary: We Need a Science White House
• Congressman Jerry McNerney to Join CHI for Roundtable in Washington, D.C.
• Devising an Early Attack on Alzheimer’s
• Diabetes Education Event Will Present Revolutionary New Treatments and Research to Battle California's Seventh Leading Killer
• Diabetes: Bay Area companies fighting epidemic
• Disease-Causing Genes Once Beneficial, Stanford Researchers Say
• Double-Therapy Approach Stopped Brain Cancer Recurrence
• Drug Libraries May Help Discover New Treatments
• Early Bird Registration Now Available for The Healthcare Policy Forum-Innovation at a Crossroads
• Editorial: Complexity of Biotech Drugs Means Copying Them is Risky(2)
• Executive Spotlight: CardioDX Founder and CEO Speaks About Personalizing Cardiovascular Treatments
• Executive Spotlight: Corventis CEO Speaks with CHI About New Technology to Address Most Expensive Ailment
• Executive Spotlight: Mickey Urdea, Ph.D., Chairman, CEO and Founder of Tethys Bioscience
• Executive Spotlight: Navigenics' CEO Speaks About The Future of Genetic Testing
• Executive Spotlight: Pierre Cassigneul, President and CEO, XDx
• Exelixis Drug Works Against Brain Cancer
• FDA and NIH Pledge Clear Path For Personalized Medicine
• FDA May Support New Testing Method for Drugs
• FDA to Aid Tropical Disease Research
• FDA Unveils First Major Nanotech Plan
• Findings Show Promise for Alzheimer’s Detection
• Former House Majority Leader Touts the Impact of Biomed Industry
• Gel Shows Promise for Cutting H.I.V. Infection Rates in African Women
• Genentech Cancer Drug Approved for Kidney Cancer
• Genentech Gains Approval for New Indication For Lucentis
• Genetic Test Helps Prognosis for Patients with Colon Cancer
• Gen-Probe Says Business is Good
• Gilead’s Drug Trial Shows Half of Patients Successfully Lowered Blood Pressure
• Good News for 18 million Americans Struggling with Obstructive Sleep Apnea
• Growth Industry in California
• IBM, Roche to Build Gene Machine
• Insufficient Sleep: A Growing Problem Among Americans
• July a Landmark Month for FDA: Meetings to Change Landscape for Industry
• Life Sciences Firms to Get Boost from New Federal Program
• Life Sciences Industry Applauds Jerry Hill's Appointment to Chair Biotechnology Committee
• Media - California’s Biomedical Industry is ‘Recession Resilient’
• Media: California’s Biomedical Industry is ‘Recession Resilient’
• Medtronic Launches Bone Cement
• MIT Seeking Nominees $500,000 Prize
• Nanotechnology New Area of Research for Cancer Therapy
• Navigenics and Scripps to Team Up to Study Patient Behavior
• New Approach to H.I.V. Vaccine Offered
• New Breast Cancer Diagnostic Tests Introduced
• New CHI Blog Interview with Joshua Makower, ExploraMed
• New Deals Energize Biotech Sector
• New Guidelines Could Lead to Earlier Alzheimer’s Detection
• New Heart Devices Transmit Information to Physicians
• New HIV Therapy Boosts Immune Systems
• New Pediatric Cancer Research Center Opens in San Diego
• New report finds stagnant NIH funding shackling young researchers
• New Research Center to Launch at Stanford University
• New Test Approved for Early HIV Detection
• New test predicts risk of post-surgery kidney injury
• New Treatment Option for Prostate Cancer Patients
• NIH Doles Out $400K for Heart-Related MiRNA Research
• Non-Hodgkin's cancer patients living longer according to new study
• Non-Profit Foundations Funding Research on “Orphan Diseases”
• Onyx Begins Phase 3 Trial Testing Multiple Myeloma Treatment
• Onyx Says Drug Candidate Slows Cancer
• Opinion: To jump-start recovery, innovate
• Orexigen Signs $1B Deal with Takeda on Obesity Drug
• PBS to Air Three-Part Series on Rare Disease Diagnosis through Technology
• Pfizer Abandons Plans to Build Biotech Research Center in San Francisco
• Pfizer Expands Into Rare Diseases with FoldRx Buy
• Pfizer To Focus on Rare Diseases
• PODCAST: Personalized Medicine is Transforming Healthcare
• Presidential Council Suggests Changes to Speed Vaccine Production
• Protein Detected in Brain Might Shed Light on Alzheimer's
• Proteus Biomedical Prescribes 'Smart Pill'
• Proteus Biomedical: Smart Pills the Wave of the Future
• Redefining Disease May Aid in Better Diagnostics, Therapies
• Report Calls Private Sector Funding 'Critical' to Biomedical Innovation
• Report Shows the Medical Technology Industry is Strong Contributor to U.S. Economy
• Restoring Our Innovative Edge
• Reversing California's Downward Trend: OpEd by Carl Hull, Gen-Probe Incorporated
• Roche Melanoma Drug Shrinks Tumors in 80% of Patients
• Roche Offers $43.7 Billion for Rest of Genentech
• Roche Unveils New Cancer Drug Data
• Salk to Lead $21 Million AIDS Study
• San Diego Biotechs Receive Stem Cell Grants
• Sanford-Burnham Study Finds Cancer Fighting Potential in Painkiller
• Sangamo Upbeat on Drug for Diabetic Nerve Damage
• Scripps, Sanofi to Collaborate on Personalized Medicine
• Sequenom to Expand in Michigan
• Silicon Valley Biomedical Sector is Growing Despite Recession
• Speakers Announced for Environmental Summit
• Sponsorship Deadline March 6 for Celebration of California Biomedical Innovation Event in D.C.
• SRI International Chief: Healthcare Experiencing Biggest Transformation in History
• SRI, Stanford Partner to Drive New Device Offerings
• Stanford Researchers Receive Grants for Stem Cell Research
• Stanford Scientists Discover Stem Cell Advance for Stroke Treatment
• Taxation and Healthcare Reform: The Impact on Innovation
• The Future of Personalized Medicine
• The Jobs Tax Officially Qualifies for the November Ballot
• The National Cancer Institute Cancer Human Biobank (caHUB) Public Information Meeting
• Three San Diego Companies Battle Obesity
• TSRI Researchers Discover Potential Drug Targets for Sepsis
• Turning Personalized Medicine into Reality
• U.S. Earns Highest Ranking Among World Biotech Leaders
• UC Davis Researcher Awarded Grant to Explore Nanotechnology Cancer-Fighting Technique
• UC San Diego Earns Top Ranking
• UCSD Forms New Medical Engineering Institute
• UCSD Researchers Devise Solution to Sticky Heart Sensor Problem
• UCSD Researchers Report Success with Wireless Glucose Monitor
• UCSD Will Use $37.2 Million Grant for Translating Research into Treatments
• UCSD Wins $10 Million for Schizophrenia Research
• UCSF and Genentech Work Together on Neurodegenerative Diseases
• University of California to Undertake Groundbreaking Breast Cancer Study
• Vaccine Disparity Points to Need for Better Reimbursement
• Warning Over Drug Trial's Effects on Testing
• Webcast Now Available: 2010 California Biomedical Industry Report
• Wyeth Shares Rise on Promising Study of Alzheimer's Drug
• 2009 San Diego Science Festival Expo Day April 4 in San Diego
• A Record $1 Billion for UCSD Research
• Analyst Discusses State's Continued Budget Problems
• Another Inconvenient Truth
• Asm. Jerry Hill Works to Retain and Recruit Biotech Firms in California
• Bill to Develop Biotechnology Workforce Goes to the Governor
• Biotechs Struggle for Funding
• California Attracts $4 Billion in Q2 Venture Capital Money
• California Public Colleges and Universities Join Together to Protect Higher Education Budgets
• Celgene Expands Cancer Drug Portfolio with $2.9 Million Abraxis Buy
• CHI Congressional Briefing: National Survey Indicates Latinos and Blacks in America Twice as Likely as Caucasians to Be Diagnosed with Diabetes
• CHI Encourages Members to Support National Lab Day
• CHI Honors Assembly Members Jerry Hill and Nathan Fletcher
• CHI Hosts Rep. Susan Davis at Preuss School
• CHI Letter Supports NIH, Preparedness and STEM Education Funding
• CHI Letter Urges Support for Stimulus Provision Targeting Small Biomedical Firms
• CHI Submits Comparative Effectiveness Research Letter to the California Delegation
• CHI Supports Greater Funding for Higher Education
• CHI Supports Latino Diabetes Awareness Resolution
• CHI Supports Research and Hope for Patients of Rare Diseases
• CHI Urges State Legislators toStabilize Higher Education Funding
• CHI Voices Support For Important NIH and Other Funding Priorities
• Deals Abound, Giving Investors New Hope
• Desperately Seeking Cures
• Environmental Summit Hotel Reservation Deadline Feb. 19
• Fueling Biotech Innovation Across the Nation
• Fund Firms Buy Back into Biotech Sector
• Gates Foundation encourages new health ideas
• Gladstone Institutes Receives $4.25 Million for Biomedical Research
• Gladstone Named at Top of List for Grad Schools
• Google Announces Venture Capital Initiative
• Grant to Boost Biotech Sector in San Diego
• Helping New Technologies Grow Into Businesses, the San Diego Way
• Investments Up For Bay Area Biotech Companies
• Invitrogen Foundation to Raise Awareness of Life Sciences
• Kids Launch Rockets, Rep. Honda Launches STEM Education Bill
• La Jolla institutes set sights on Florida
• New Directors Join the California Healthcare Institute Board of Directors
• New Nonprofit to Help With Diagnostics, Treatment for Ovarian Cancer
• New Podcasts: 15th Annual Life Sciences Venture Forum 2009
• Nontypical Research Receives Funding from Gates Foundation
• NSF Awards $3 Million to Start a National Science Festival Network
• PODCAST: What Will it Take to Save 'Crown Jewel' UC System: Hear from Industry Experts in New CHI Podcast
• President Supports an Increase in Funding to Basic Science
• PWC Report: Med Device Deals Up in First Half of the Year
• Record Turnout for Life Sciences Day in the State Capitol
• Report: California is Losing Manufacturing Jobs
• Report: K-12 Engineering Education May Boost Learning of Science and Math
• Report: U.S. Losing Competitive Edge
• San Diego Biotechs Raise Concerns About Lack of Funding
• San Jose State University Receives Stimulus Grant for Biotech
• Sanford-Burnham Plays Host to Future Scientists
• Searching For a Hero For The Biomedical Industry
• Significant Milestone Reached in Addressing Biomedical Workforce Needs
• Small Biotech Firms Feel Financial Crunch
• Stanford Health Library Benefits Community
• Stanford to Limit Industry Financing
• State Stem Cell Funds Helping Build Better California
• Steady Pace for Venture Capital Deals
• Stimulus Funds Available for Medical Research
• Study Reveals Significant Neglect in Early Science Education
• Survey Finds Venture Capital Valuations Up for Life Sciences Companies
• The 2009 San Diego Science Festival
• Today is Your Last Chance to Register for CHI's Environmental Summit
• U.S. Students Lag in Life Sciences
• UC Board of Regents Confirm Desmond-Hellmann as Chancellor
• UCSD Professor Works to Increase Diversity in Biosciences
• UCSF to name building after biotech pioneer Bill Rutter
• UCSF's Elizabeth Blackburn Receives Nobel Prize For Medicine
• University of California Nominates Genentech Executive as Chancellor
• University of California Nominates Genentech Executive as Chancellor
• University of California San Francisco a Strong Economic Driver
• University of California, Irvine Received $45 Million Grant to Study Infectious Diseases
• VCs Seek New FDA Review Path
• Venture Capital Firms Focus on the Life Sciences
• Venture capital spreads the wealth around the country